Interferon in the prevention of genital herpes recurrence
- PMID: 3789694
- PMCID: PMC176490
- DOI: 10.1128/AAC.30.4.608
Interferon in the prevention of genital herpes recurrence
Abstract
Patients with genital herpes were treated three times weekly for 12 weeks with 3 X 10(6) IU of alpha 2b interferon (20 patients) or placebo (17 patients) administered by subcutaneous injection in a double-blind trial. Interferon had minimal effects on the suppression of recurrences and moderate toxicity (chills, fever, fatigue, and leukopenia), suggesting that this route and dosage of interferon may not be clinically useful for this indication.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
